Back to News
Market Impact: 0.28

BofA raises Linde stock price target on higher 2026 earnings By Investing.com

LINJPMSMCIAPP
Analyst EstimatesAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsCapital Returns (Dividends / Buybacks)
BofA raises Linde stock price target on higher 2026 earnings By Investing.com

BofA Securities raised its price target on Linde to $532 from $525 and kept a Buy rating, citing a modestly higher 2026 EPS estimate of $17.88 versus $17.86 and a lower 7.3% WACC. The company also continues to show strong fundamentals, including a first-quarter EPS beat of $4.33 vs. $4.27 consensus and a 34-year streak of dividend increases. Some caution remains as the Woodside project is being pushed into 2027 and 2026 full-year guidance is only in line with consensus.

Analysis

The market is treating this as a clean valuation reset, but the real signal is that Linde’s earnings durability is becoming more schedule-dependent than demand-dependent. A project slip into 2027 does not just defer revenue; it mechanically delays operating leverage and keeps near-term multiple expansion capped because investors pay up for visible volume ramps, not just pricing power. In other words, the stock’s premium is now hostage to execution cadence, so any further delay would likely compress sentiment faster than consensus models can rebase earnings. The second-order winner is not necessarily another industrial gas peer, but capital goods and EPC exposure tied to delayed project spend: a commissioning push typically means deferred orders, later milestone billing, and less working-capital release across the project chain. For Linde itself, the counterbalance is that the business still has a high-quality defensive profile, so downside may remain shallow unless guidance revisions begin to spill into 2027 as well. That makes the next two quarters the key window: if management can prove the delay is isolated, the stock can hold the multiple; if not, the market will likely re-rate it from "compounder" toward "steady grower." The consensus may be underestimating how much of the recent optimism is already embedded in the stock after a strong run. Incremental target hikes on small estimate changes usually signal that sell-side conviction is consolidating rather than expanding, which often means less upside than the headlines imply. The contrarian take is that Linde is still a good business, but not obviously a good trade here: valuation leaves little room for another timing miss, especially with the target set only modestly above spot.